1

Non-coding RNAs expression in SARS-CoV-2 infection: pathogenesis, clinical significance, and therapeutic targets

Signal Transduct Target Ther

2023,8(1):441.

Q1.IF=40.8

2

Pre-B-cell leukemia transcription factor 1 contributes to liver fibrosis by enabling IL-7 signaling in HSC

Hepatology

2026 Feb 1;83(2):276-293.

Q1.IF=15.8

3

Sleep health in China: status, challenges, and promotion strategies

The Lancet Public Health

2025 Nov 9:S2468-2667(25)00250-6.

Q1.IF=25.2

4

Child and adolescent mental health policy advancement in China

The Lancet Psychiatry

2025 Aug 4:S2215-0366(25)00240-8.

Q1.IF=24.8

5

Etomidate misuse: a digital era threat to youth and a call for anticipatory control

The lancet. Psychiatry

2025 Oct;12(10):732-733

Q1.IF=24.8

6

Weakly negative permittivity: metal–organic frameworks derived cobalt nanoparticles encapsulated by positive-hexagon-shaped carbon nanosheets

Adv. Compos. Hybrid Ma

2024, 7(4):2-11

Q1.IF=23.2

7

The glymphatic system in psychiatric disorders: a new perspective

Science bulletin

2025

Q1.IF=21.1

8

PTBP1 Lactylation Promotes Glioma Stem Cell Maintenance through PFKFB4-Driven Glycolysis

Cancer Res

2025 Feb 17;85(4):739-757.

Q1.IF=16.6

9

Apoptotic Cell-Mimicking Nanocarriers Enhance Splenic Red Pulp Delivery through Lipid Pool Modulation

ACS Nano

2025, 19(19): 18570-18585

Q1.IF=16

10

Pre-B-Cell leukemia transcription factor 1 contributes to liver fibrosis by enabling IL-7 signaling in hepatic stellate cells

Hepatology

2026 Feb 1;83(2):276-293.

Q1.IF=15.8

11

Psychoactive substances: novel molecular insights and therapeutic potential for Alzheimer's disease

Transl Neurodegener

2025 Jul 25;14(1):38.

Q1.IF=15.2

12

Long-term exercise enhances meningeal lymphatic vessel plasticity and drainage in a mouse model of Alzheimer's disease

Translational neurodegeneration

2025 Jul 25;14(1):37.

Q1.IF=15.2

13

SGK1 drives hippocampal demyelination and diabetes-associated cognitive dysfunction in mice

Nat Commun

2025 ,16(1):1709.

Q1.IF=14.7

14

In vivo spatiotemporal mapping of proliferation activity in gliomas via water-exchange dynamic contrast-enhanced MRI

Theranostics

2025 Mar 24;15(10):4693-4707

Q1.IF=13.3

15

Multimorbidity, cognitive phenotypes, and Alzheimer’s disease plasma biomarkers in older adults: A population-based study

Alzheimers Dement

2024 ,20(3):1550-1561

Q1.IF=13.0

16

Cardiometabolic multimorbidity, peripheral biomarkers, and dementia in rural older adults: The MIND-China study

Alzheimers Dement

2024 ,20(9):6133-6145

Q1.IF=13.0

17

Synergistic associations of CD33 variants and hypertension with brain and cognitive aging among dementia-free older adults: A population-based study

Alzheimers Dement

2024 ,20(10):7193-7204.

Q1.IF=13.0

18

Association of polygenic risk scores with Alzheimer's disease and plasma biomarkers among Chinese older adults: A community-based study

Alzheimers Dement

2024 ,20(10):6669-6681.

Q1.IF=13.0

19

A phosphatidylserine-targeted self-amplifying nanosystem improves tumor accumulation and enables efficient tumor therapy by modulating anticancer immunity.

Biomaterials

2026 Jan:324:123526.

Q1.IF=12.9

20

Microglial BDNF modulates arketamine’s antidepressant-like effects through cortico-accumbal pathways

Sci Adv

2025 Jul 11;11(28):eadv5986.

Q1.IF=12.5

21

Quantitative Cerebral Blood Volume Image Synthesis from Standard MRI Using Image-to-Image Translation for Brain Tumors

Radiology

2023,308(2):e222471.

Q1.IF=12.1

22

Inhibition of Gpx4-mediated ferroptosis alleviates cisplatin-induced hearing loss in C57BL/6 mice

Mol Ther

2024,32(5):1387-1406

Q1.IF=12.1

23

Inhibiting Ferroptosis in Type I Hair Cells of the Utricle Might Be a Promising Strategy for Treating Cisplatin-Induced Vestibulotoxicity

Molecular therapy

2025 Oct 16:S1525-0016(25)00853-6

Q1.IF=12.0

24

Biomimetic lipid nanocarriers overcome hypoxia barriers in lung cancer therapy

Journal of controlled release

2025 Oct 10:386:114100.

Q1.IF=11.5

25

Physical and biopsychosocial frailty, cognitive phenotypes, and plasma biomarkers for Alzheimer's disease in Chinese older adults: A population-based study

Alzheimer's & dementia

2025 May;21(5):e70303

Q1.IF=11.1

26

To nap or not? Evidence from a meta-analysis of cohort studies of habitual daytime napping and health outcomes

Sleep Med Rev

2024,78:101989.

Q1.IF=11.2

27

C-C motif chemokines ligand 7 contributes to metabolic dysfunction-associated steatotic liver disease by enabling redox_x0002_sensitive induction of hypermethylated in cancer 1

Metabolism

2025 Jul:168:156242.

Q1.IF=10.9

28

Cannabidiol ameliorates cognitive decline in 5×FAD mouse model of Alzheimer's disease through potentiating the function of extrasynaptic glycine receptors.

Molecular Psychiatry

2025,30(5):1817-1827.

Q1.IF=10.8

29

Intermittent Fasting and Neurodegenerative Diseases: Molecular Mechanisms and Therapeutic Potential

Metabolism

2024 ,164:156104.

Q1.IF=10.8

30

Redox-sensitive epigenetic activation of SUV39H1 contributes to liver ischemia-reperfusion injuryRedox Biology

Redox Biol

2024,78:103414.

Q1.IF=10.7

31

Effect of natural rewards on substance use disorder: an incentive sensitization perspective

Biol Psychiatry

2025 Jun 13:S0006-3223(25)01248-X.

Q1.IF=10.4

32

Associations between trajectories of plasma biomarkers for Alzheimer’s disease, brain structures, and cognitive function: a prospective cohort study in the UK Biobank。

Mol Psychiatry

2025 Aug 28.

Q1.IF=10.1

33

Gut microbiota regulate insomnia-like behaviors via gut-brain metabolic axis

Molecular psychiatry

2025 Jun;30(6):2597-2611.

Q1.IF=10.1

34

Incidence and risk factors of antidepressant withdrawal symptoms: a meta-analysis and systematic review

Molecular psychiatry

2025 May;30(5):1758-1769.

Q1.IF=10.1

35

Depression and antidepressant use in pregnancy and adverse maternal and offspring outcomes: a systematic review and meta-analysis

Molecular psychiatry

2025 Oct 2

Q1.IF=10.1

36

Practical AI application in psychiatry: historical review and future directions

Molecular psychiatry

2025 Sep;30(9):4399-4408.

Q1.IF=10.1